Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 226

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 226
---
 statement of which this prospectus is a part will be sold and (ii) no other shares of common stock will be acquired or sold by the applicable selling stockholders before completion of this offering. However, the selling stockholders may sell all, part or none of their shares of common stock offered pursuant to this prospectus and may sell all, part or none of their common stock pursuant to one or more exemptions from the registration provisions of the Securities Act. |

| (2) | Excludes, for beneficial ownership purposes, 188,680 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (3) | Excludes, for beneficial ownership purposes, 9,436 warrants to purchase common stock purchased in the (1) Offering that are not exercisable until December 3, 2025. |

| (4) | Excludes, for beneficial ownership purposes, 20,000 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (5) | Excludes, for beneficial ownership purposes, 75,472 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (6) | Excludes, for beneficial ownership purposes, 37,736 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (7) | Excludes, for beneficial ownership purposes, 94,340 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (8) | Excludes, for beneficial ownership purposes, 113,208 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (9) | Excludes, for beneficial ownership purposes, 150,944 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (10) | Excludes, for beneficial ownership purposes, 75,472 warrants to purchase common stock purchased in the Offering that are not exercisable until December 3, 2025. |

| (11) | The securities reported are held directly by the James D. Kollefrath 2017 Irrevocable Trust, and may be deemed to be beneficially owned by Caroline Nyberg, as trustee. Caroline Ny